LGLuis-Eugenio Graniel-Palafox

Luis-Eugenio Graniel-Palafox

*This is an algorithmically generated author record based on publicly available information.

Luis-Eugenio Graniel-Palafox has a total of 24 co-authors. Here are the top co-authors by number of shared publications:

  • Guillermo Cueto-Robledo

    Pulmonary Circulation Clinic, Hospital General de México 'Dr. Eduardo Liceaga', 06720, Mexico City, Mexico; Cardiorespiratory emergencies, General Hospital of México, Dr. Eduardo Liceaga, 06720, Mexico City, Mexico; Faculty of Medicine, National Autonomous University of Mexico, 04510, Mexico City, Mexico

    4 shared publications
  • Dulce-Iliana Navarro-Vergara

    Pulmonary Circulation Clinic, Hospital General de México 'Dr. Eduardo Liceaga', 06720, Mexico City, Mexico; Cardiorespiratory emergencies, General Hospital of México, Dr. Eduardo Liceaga, 06720, Mexico City, Mexico

    3 shared publications
  • Ernesto Roldan-Valadez

    Division of Research, Instituto Nacional de Rehabilitacion Luis Guillermo Ibarra Ibarra, 14389, Mexico City, Mexico; I.M. Sechenov First Moscow State Medical University (Sechenov University), Department of Radiology, 119992, Moscow, Russia

    3 shared publications
  • Marisol Garcia-Cesar

    Pulmonary Circulation Clinic, Hospital General de México 'Dr. Eduardo Liceaga', 06720, Mexico City, Mexico; Cardiorespiratory emergencies, General Hospital of México, Dr. Eduardo Liceaga, 06720, Mexico City, Mexico

    2 shared publications
  • Benjamin Orozco-Zuñiga

    Ginecology Department, Hospital General de México “Dr Eduardo Liceaga”, Mexico City, Mexico

    1 shared publication
  • Eduardo Lozano-Melendez

    Faculty of Medicine and Nutrition of the Juarez University of the State of Durango, Durango, Durango, Mexico

    1 shared publication

Latest Publications

  • In situ pulmonary arterial thrombosis in pulmonary arterial hypertension: Diagnostic differentiation, imaging criteria, and management—A narrative review with an institutional case-series snapshot

    by María-José Bravo-Vásquez, Guillermo Cueto-Robledo, Ernesto Roldan-Valadez, Dulce-Iliana Navarro-Vergara, Luis-Eugenio Graniel-Palafox, Jonathan Ruiz-Ruiz, Nicolai Gonzalez-Stoylov, Erick-Mauricio Garcia-Luna


    • 14 November 2025
      • p. 103209

    In situ Pulmonary Arterial Thrombosis in Pulmonary Arterial Hypertension: Diagnostic Differentiation, Imaging Criteria, and Management-A Narrative Review with an Institutional Case-Series Snapshot: In situ PAT in PAH: Imaging & Management.

    by María-José Bravo-Vásquez, Guillermo Cueto-Robledo, Ernesto Roldan-Valadez, Dulce-Iliana Navarro-Vergara, Luis-Eugenio Graniel-Palafox, Jonathan Ruiz-Ruiz, Nicolai Gonzalez-Stoylov, Erick-Mauricio Garcia-Luna

    Pulmonary arterial hypertension (PAH) creates a prothrombotic environment that may result in in situ pulmonary arterial thrombosis (PAT), a subtype that can resemble pulmonary embolism and chronic thromboembolic pulmonary hypertension (CTEPH) but requires different management. We conducted a narrative review of epidemiology, mechanisms, diagnostic differentiation, imaging (CT pulmonary angiography [CTPA], ventilation-perfusion [V/Q] scanning, echocardiography), and treatment of in situ PAT, and incorporated an institutional retrospective series (screened 2020-2025). In situ PAT typically appears on CTPA as central or wall-adherent thrombi within markedly dilated proximal pulmonary arteries, often without stenosis. Early V/Q scanning is useful to rule out CTEPH; non-segmental or mottled perfusion favors Group 1 PAH. Caliber metrics (PA diameter, PA/Ao) and RV strain indices (RV/LV, TAPSE) support but do not by themselves establish the diagnosis. Of 364 PAH patients screened, 7 (1.9%) met imaging criteria for in situ PAT; mean age 42 years, 71% female, 43% congenital heart disease. All had PA ≥30 mm and RV/LV ≥1; 71% had aneurysmal PA ≥40 mm; 71% had negative DVT Doppler. Functional and hemodynamic impairment was substantial. A stepwise workflow-DVT assessment, V/Q to exclude CTEPH, and targeted CTPA morphology interpreted with hemodynamics-facilitates accurate classification of in situ PAT and avoids misdirected CTEPH interventions. Therapy should begin with PAH-targeted treatment; anticoagulation should be individualized according to phenotype, bleeding risk, and clinical course.


  • Saddle pulmonary embolism: results of a series of patients undergoing pharmaco-mechanical thrombolysis

    by Benjamin Orozco-Zuñiga, Guillermo Cueto-Robledo, Leslie-Marisol Gonzalez-Hermosillo, Galileo Escobedo, Dulce-Iliana Navarro-Vergara, Marisol Garcia-Cesar, Maria-Berenice Torres-Rojas, Luis-Eugenio Graniel-Palafox, Hector R. Cajigas, Jose-Luis Cerano-Fuentes

    This study aimed to evaluate the clinical presentation and outcomes of patients with saddle pulmonary embolism (SPE) undergoing pharmaco-mechanical thrombolysis, highlighting the role of specialized multidisciplinary care. This retrospective study describes a series of cases in a Mexican tertiary care hospital with a newly established Pulmonary Embolism Rapid Response Team (PERT). The study took place in a tertiary care hospital in Mexico. Patients or participants: Twelve patients diagnosed with saddle pulmonary embolism were included in the study. All patients underwent catheter-guided thrombolysis and fragmentation as part of their treatment. The main variables of interest included clinical presentation, hemodynamic stability, and outcomes following catheter-directed therapy. Catheter-guided thrombolysis and fragmentation led to significant hemodynamic improvement in all patients. The intervention, combined with standard anticoagulation, showed promise in stabilizing hemodynamics and reducing thrombus burden, potentially improving outcomes in patients with SPE. Specialized multidisciplinary care, as provided by a Pulmonary Embolism Rapid Response Team, is crucial in managing saddle pulmonary embolism. The study offers insights into the safety and efficacy of endovascular interventions in this patient population.


  • Open Access

    Images in Vascular Medicine: Multiple Rasmussen aneurysms in noncavitary, multidrug-resistant tuberculosis

    by Guillermo Cueto-Robledo, Luis-Eugenio Graniel-Palafox, Marisol Garcia-Cesar, Hector-Daniel Cueto-Romero, Ernesto Roldan-Valadez


  • Open Access

    Adult Nesidioblastosis in Chronic Kidney Disease

    by Eduardo Lozano-Melendez, Mercedes Aguilar-Soto, Luis Eugenio Graniel-Palafox, Laura Elena Ceceña-Martínez, Rafael Valdez-Ortiz, Fabio Solis-Jimenez

    Context. Nesidioblastosis is a rare cause of hyperinsulinemic hypoglycemia in adults. The diagnosis is further complicated in patients with kidney failure, since impaired renal function can cause hypoglycemia by itself and diagnostic criteria for this clinical scenario have not been developed yet. Case Description. We present the case report of a 36-year-old patient with end stage chronic kidney disease who presented to the emergency department because of hypoglycemia. However, the patient’s hypoglycemia did not respond well to medical treatment; the diagnosis of hyperinsulinemic hypoglycemia was made due to the presence of inappropriately high levels of insulin, proinsulin, and C-peptide during an episode of hypoglycemia. Imaging studies were performed without any conclusive findings; so selective intra-arterial pancreatic stimulation with hepatic venous sampling (SACTS) was done. Based on the results of this study the patient was referred for subtotal pancreatectomy. Classic criteria for the diagnosis of insulinoma with SACTS required a 2-fold increase in insulin levels but newer criteria suggest thresholds that are useful in the differential diagnosis of insulinoma and nesidioblastosis. In our patient, the former criteria were positive; however, the new criteria were not compatible with insulinoma but with nesidioblastosis, which was the final histopathological diagnosis. Conclusion. This seems to be the first case report of a patient with end stage chronic kidney disease and nesidioblastosis, as well as the first case of hyperinsulinemic hypoglycemia in the context of kidney failure diagnosed by SACTS. We consider this method to be very useful in patients with renal impairment because peripancreatic insulin levels do not depend on the renal function.